Benitec Biopharma (BNTC) Other Operating Expenses (2019 - 2025)

Benitec Biopharma has disclosed Other Operating Expenses across 7 years of filings, most recently posting -$5.6 million for Q1 2025.

• Other Operating Expenses for Q1 2025 came in at -$5.6 million, down 185100.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.6 million (down 209.61% YoY), and the FY2024 annual result was -$108000.0, changed N/A from the prior year.
• Other Operating Expenses came in at -$5.6 million for Q1 2025 at Benitec Biopharma, down from $5.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $5.1 million in Q4 2024 to a low of -$5.6 million in Q1 2025.
• The 5-year median for Other Operating Expenses is $1000.0 (2021), against an average of -$71875.0.
• Across the five-year window, Other Operating Expenses soared 507100.0% in 2024 and plunged 185100.0% in 2025, its largest moves.
• Benitec Biopharma's Other Operating Expenses stood at $1000.0 in 2021, then soared by 800.0% to $9000.0 in 2022, then plunged by 88.89% to $1000.0 in 2023, then jumped by 507100.0% to $5.1 million in 2024, then slumped by 209.54% to -$5.6 million in 2025.
• The last three Other Operating Expenses figures came in at -$5.6 million (Q1 2025), $5.1 million (Q4 2024), and -$3000.0 (Q1 2024), per Business Quant data.